Inflammation Related to Muted Pleasure Feelings in Depression
the Psychiatry Advisor take:
People that have high levels of inflammation in their brain may also have more stubborn symptoms of depression.
Jennifer Felger, PhD, of Emory University School of Medicine, Atlanta, and colleagues examined 48 patients with depression. Those with high levels of high levels of the inflammatory marker CRP (C-reactive protein) were linked with a “communication failure,” as seen through brain scans, between regions of the brain important for motivation and reward.
The findings, according to Felger, reinforce the idea that high-inflammation depression is a distinct form of the mood disorder, and should have treatments developed specifically for it, she wrote in the journal Molecular Psychiatry.
In particular, many people with depression, despite taking antidepressants, still suffer from anhedonia, or the inability to feel pleasure. And in particular, those with high CRPs levels were particular susceptible to it.
“Our data suggest that by blocking inflammation or its effects on the brain, we may be able to reverse anhedonia and help depressed individuals who fail to respond to antidepressants,” Felger said in a statement.
The researchers are next planning to test whether L-DOPA, a drug that targets the brain chemical dopamine, can increase connectivity in reward-related brain regions in patients with high-inflammation depression.
Depressed patients with high levels of an inflammatory marker in their blood were particularly susceptible to anhedonia.
About one third of people with depression have high levels of inflammation markers in their blood. New research indicates that persistent inflammation affects the brain in ways that are connected with stubborn symptoms of depression, such as anhedonia, the inability to experience pleasure.
The results were published online in Molecular Psychiatry.
The findings bolster the case that the high-inflammation form of depression is distinct, and are guiding researchers' plans to test treatments tailored for it.
Anhedonia is a core symptom of depression that is particularly difficult to treat, says lead author Jennifer Felger, PhD, assistant professor of psychiatry and behavioral sciences at Emory University School of Medicine and Winship Cancer Institute.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Abstinence From Regular Cannabis Use Improves Memory Among Adolescents, Young Adults
- Group Cognitive Behavioral Therapy Is Effective Treatment for Adolescent Anxiety
- Health and Social Factors Predict Changes in Depressive Symptoms in Women
- ASD Risk on Offspring With Prenatal Use of Medication Affecting Neurotransmitter System
- Effects of Impaired Glucose Metabolism on Lithium and Other Mood Stabilizers
- Cannabis Use, Cannabis Use Disorder Linked to Psychotic, Depressive Symptoms
- Association Between Opioid and Benzodiazepine Misuse and Suicidal Ideation
- The Intersection of Eating and Alcohol Disorders: Detecting and Managing "Drunkorexia"
- Heart Rate Variability Predicts Treatment Response in Anxious Depression
- Impulsivity in Bipolar Disorder, Borderline Personality Disorder, ADHD
- Can Examining Marginalization Identify Gaps in Medical or Nutritional Care?
- Efficacy, Safety of Long-Term Ketamine Administration Still In Question
- Vulnerability to Psychosocial Disability in Psychosis
- Behavioral Health Screening Advocated for Teens With Epilepsy
- KCNQ Channel Potentiator Ezogabine Delivers Promising Results in Major Depressive Disorder